Biotechnology (1,036) | Real Estate (1,036)

Browse by Subcategory

Lease Agreements (1,033 contracts)
Mortgage Agreements (3)

Browse by Company

89bio, Inc. (3 contracts)
ACADIA PHARMACEUTICALS INC (2)
Achaogen, Inc. (1)
ACHIEVE LIFE SCIENCES, INC. (2)
Actinium Pharmaceuticals, Inc. (1)
Adaptimmune Therapeutics PLC (4)
ADiTx Therapeutics, Inc. (1)
ADURO BIOTECH, INC. (2)
Advaxis, Inc. (2)
Adverum Biotechnologies, Inc. (5)
Aeglea BioTherapeutics, Inc. (1)
Aerovate Therapeutics, Inc. (2)
AGENUS INC (1)
AgeX Therapeutics, Inc. (1)
AGIOS PHARMACEUTICALS INC (5)
AILERON THERAPEUTICS INC (1)
Aimmune Therapeutics, Inc. (2)
AKCEA THERAPEUTICS, INC. (1)
Akebia Therapeutics, Inc. (3)
Akero Therapeutics, Inc. (1)
Akouos, Inc. (2)
ALBIREO PHARMA, INC. (5)
Aldeyra Therapeutics, Inc. (2)
Alector, Inc. (2)
Aligos Therapeutics, Inc. (2)
Alkermes plc. (3)
Allakos Inc. (1)
Alliqua BioMedical, Inc. (1)
Allogene Therapeutics, Inc. (6)
Allovir, Inc. (4)
ALNYLAM PHARMACEUTICALS, INC. (2)
Alpha Healthcare Acquisition Corp. (5)
ALPINE IMMUNE SCIENCES, INC. (1)
AMARIN CORP PLC (3)
AMICUS THERAPEUTICS, INC. (1)
AmpliPhi Biosciences Corp (2)
ANAPTYSBIO INC (3)
Anika Therapeutics (3)
Annexon, Inc. (2)
Apellis Pharmaceuticals, Inc. (4)
APPLIED GENETIC TECHNOLOGIES CORP (4)
Applied Molecular Transport Inc. (2)
Aptevo Therapeutics Inc. (3)
AquaBounty Technologies, Inc. (1)
AQUINOX PHARMACEUTICALS, INC (5)
Aravive, Inc. (1)
ARCA biopharma, Inc. (3)
Arcellx, Inc. (1)
Arcturus Therapeutics Holdings Inc. (4)
Arcus Biosciences, Inc. (2)
Arcutis Biotherapeutics, Inc. (2)
ARDELYX, INC. (2)
Aridis Pharmaceuticals, Inc. (1)
ARROWHEAD PHARMACEUTICALS, INC. (7)
Arsanis, Inc. (4)
Artiva Biotherapeutics, Inc. (1)
ARYA Sciences Acquisition Corp II (2)
Atara Biotherapeutics, Inc. (2)
Atreca, Inc. (5)
aTYR PHARMA INC (1)
Aura Biosciences, Inc. (1)
Aurinia Pharmaceuticals Inc. (3)
AVEO PHARMACEUTICALS INC (2)
Avidity Biosciences, Inc. (4)
Avita Therapeutics, Inc. (2)
Axcella Health Inc. (3)
Ayala Pharmaceuticals, Inc. (1)
BCTG Acquisition Corp. (1)
Beam Therapeutics Inc. (2)
BICYCLE THERAPEUTICS Ltd (1)
Big Cypress Acquisition Corp. (2)
BIO-PATH HOLDINGS INC (1)
BioAtla, Inc. (1)
BioCardia, Inc. (1)
BIOCEPT INC (2)
Biomea Fusion, Inc. (2)
BioRestorative Therapies, Inc. (1)
BIOSPECIFICS TECHNOLOGIES CORP (2)
BIOTIME INC (1)
BioXcel Therapeutics, Inc. (1)
Black Diamond Therapeutics, Inc. (2)
Blue Water Vaccines Inc. (1)
bluebird bio, Inc. (4)
Blueprint Medicines Corp (2)
Bolt Biotherapeutics, Inc. (4)
BridgeBio Pharma, Inc. (1)
C4 Therapeutics, Inc. (2)
Cabaletta Bio, Inc. (2)
Calithera Biosciences, Inc. (1)
CANCER GENETICS, INC (4)
Candel Therapeutics, Inc. (2)
CAPRICOR THERAPEUTICS, INC. (1)
CareDx, Inc. (4)
Caribou Biosciences, Inc. (3)
CASI Pharmaceuticals, Inc. (1)
CASTLE BIOSCIENCES INC (15)
Castle Creek Biosciences, Inc. (3)
CATABASIS PHARMACEUTICALS INC (1)
CATALYST BIOSCIENCES, INC. (1)
CATALYST PHARMACEUTICALS, INC. (1)
Celcuity Inc. (4)
Celldex Therapeutics, Inc. (5)
Cellectar Biosciences, Inc. (1)
Cellular Biomedicine Group, Inc. (3)
Celsion CORP (1)
Centessa Pharmaceuticals Ltd (1)
Chanticleer Holdings, Inc. (1)
Chardan Healthcare Acquisition Corp. (2)
Chelsea Worldwide Inc. (2)
ChemoCentryx, Inc. (2)
CHIMERIX INC (2)
Cidara Therapeutics, Inc. (2)
CM Life Sciences III Inc. (2)
Codiak BioSciences, Inc. (3)
Conatus Pharmaceuticals Inc. (3)
Consonance-HFW Acquisition Corp. (1)
Constellation Alpha Capital Corp. (8)
CONSTELLATION PHARMACEUTICALS INC (2)
Corbus Pharmaceuticals Holdings, Inc. (2)
Cortexyme, Inc. (2)
Corvus Pharmaceuticals, Inc. (1)
CRISPR Therapeutics AG (5)
CTI BIOPHARMA CORP (1)
Cullinan Oncology, LLC (1)
CURIS INC (2)
Cyclerion Therapeutics, Inc. (3)
Cytokinetics, Incorporated (5)
CYTRX CORP (2)
Day One Biopharmaceuticals Holding Co LLC (2)
Decibel Therapeutics, Inc. (2)
Deciphera Pharmaceuticals, Inc. (3)
Dermavant Sciences Ltd (3)
Design Therapeutics, Inc. (2)
DiaMedica Therapeutics Inc. (2)
Dicerna Pharmaceuticals Inc (2)
DYADIC INTERNATIONAL INC (3)
Dynamics Special Purpose Corp. (4)
DYNAVAX TECHNOLOGIES CORP (3)
Dyne Therapeutics, Inc. (5)
Eagle Pharmaceuticals, Inc. (1)
Edge Therapeutics, Inc. (1)
Editas Medicine, Inc. (1)
Eidos Therapeutics, Inc. (1)
Eiger BioPharmaceuticals, Inc. (1)
Emerald Bioscience, Inc. (1)
Enanta Pharmaceuticals, Inc. (3)
Entrada Therapeutics, Inc. (1)
Environmental Impact Acquisition Corp (4)
Epizyme, Inc. (1)
Erasca, Inc. (2)
EXACT SCIENCES CORP (8)
Exelixis (7)
EXICURE, INC. (1)
FATE THERAPEUTICS INC (1)
FIBROGEN INC (1)
Finch Therapeutics Group, Inc. (3)
FIVE PRIME THERAPEUTICS INC (1)
Flexion Therapeutics Inc (1)
Foghorn Therapeutics Inc. (3)
Forma Therapeutics Holdings, Inc., (4)
Forty Seven, Inc. (2)
Frequency Therapeutics, Inc. (5)
FS Development Corp. (1)
Fusion Pharmaceuticals Inc. (4)
Galecto Inc. (2)
Gemphire Therapeutics Inc. (4)
GENELUX CORP (3)
Generation Bio Co. (3)
GENOCEA BIOSCIENCES, INC. (2)
GeoVax Labs, Inc. (2)
GERON CORP (4)
GOLDENWELL BIOTECH, INC. (1)
Gossamer Bio, Inc. (1)
Grail, Inc. (3)
Graphite Bio, Inc. (2)
Gritstone Oncology, Inc. (4)
GT Biopharma, Inc. (1)
GTX INC (2)
GX Acquisition Corp. (1)
HALOZYME THERAPEUTICS INC (1)
HCW Biologics Inc. (1)
HEAT BIOLOGICS, INC. (3)
HEMISPHERX BIOPHARMA INC (2)
HERON THERAPEUTICS, INC. (2)
HISTOGENICS CORP (4)
Homology Medicines, Inc. (1)
HOOKIPA Pharma Inc. (2)
iBio, Inc. (1)
Icosavax, Inc. (1)
IDEAYA Biosciences, Inc. (4)
IDERA PHARMACEUTICALS, INC. (1)
IGM Biosciences, Inc. (2)
Immuneering Corp (1)
IMMUNOGEN INC (1)
IMMUNOMEDICS INC (1)
IMPEL NEUROPHARMA INC (1)
INFINITY PHARMACEUTICALS, INC. (1)
Inhibikase Therapeutics, Inc. (1)
Inhibrx, Inc. (2)
InMed Pharmaceuticals Inc. (1)
Inmune Bio, Inc. (1)
Inozyme Pharma, Inc. (2)
INSMED Inc (2)
Intellia Therapeutics, Inc. (3)
INTERCEPT PHARMACEUTICALS, INC. (2)
International Stem Cell CORP (3)
Invitae Corp (1)
IOVANCE BIOTHERAPEUTICS, INC. (7)
IRONWOOD PHARMACEUTICALS INC (3)
Isoray, Inc. (1)
iTeos Therapeutics, Inc. (1)
Janux Therapeutics, Inc. (1)
Jounce Therapeutics, Inc. (1)
KalVista Pharmaceuticals, Inc. (1)
Karuna Therapeutics, Inc. (2)
Karyopharm Therapeutics Inc. (1)
Keros Therapeutics, Inc. (2)
Kezar Life Sciences, Inc. (1)
Kindred Biosciences, Inc. (1)
Kiniksa Pharmaceuticals, Ltd. (2)
Kinnate Biopharma Inc. (2)
Kiromic Biopharma, Inc. (6)
Kodiak Sciences Inc. (1)
Kronos Bio, Inc. (1)
Krystal Biotech, Inc. (15)
Kura Oncology, Inc. (8)
Kymera Therapeutics, Inc. (1)
LEAP THERAPEUTICS, INC. (3)
LEXICON PHARMACEUTICALS, INC. (1)
LianBio (5)
LifeSci Acquisition Corp. (1)
Ligand Pharmaceuticals Incorporated (1)
Locust Walk Acquisition Corp. (2)
LogicBio Therapeutics, Inc. (1)
LONGEVERON LLC (1)
Lyell Immunopharma, Inc. (5)
MADRIGAL PHARMACEUTICALS, INC. (1)
Magenta Therapeutics, Inc. (2)
MANNKIND CORP (2)
MARIZYME INC (2)
MAXCYTE, INC. (9)
MeiraGTx Holdings plc (4)
Mersana Therapeutics, Inc. (2)
Merus N.V. (3)
Metacrine, Inc. (2)
Millendo Therapeutics, Inc. (5)
MiMedx Group, Inc. (2)
MIRAGEN THERAPEUTICS, INC. (7)
Mirati Therapeutics, Inc. (5)
Mirum Pharmaceuticals, Inc. (2)
Moderna, Inc. (2)
Molecular Templates, Inc. (3)
Momenta Pharmaceuticals, Inc. (2)
Monte Rosa Therapeutics, Inc. (3)
Morphic Holding, Inc. (2)
Myriad Genetics, Inc. (1)
NANOVIRICIDES, INC. (1)
NantKwest, Inc. (15)
Natera, Inc. (4)
NEUROCRINE BIOSCIENCES INC (2)
Neurotrope, Inc. (1)
NexImmune, Inc. (2)
NextCure, Inc. (3)
Nkarta, Inc. (9)
NORTHWEST BIOTHERAPEUTICS INC (2)
NOVAVAX INC (4)
Novus Therapeutics, Inc. (2)
NTN BUZZTIME INC (8)
Nurix Therapeutics, Inc. (3)
Ohr Pharmaceutical Inc (9)
Olivia Ventures, Inc. (1)
Omega Therapeutics, Inc. (2)
OncoCyte Corp (2)
Oncorus, Inc. (6)
ONCOSEC MEDICAL Inc (3)
OPGEN INC (1)
ORAGENICS INC (1)
Orchard Therapeutics plc (1)
Organogenesis Holdings Inc. (3)
ORGANOVO HOLDINGS, INC. (6)
Oric Pharmaceuticals, Inc. (2)
Outlook Therapeutics, Inc. (1)
Passage BIO, Inc. (4)
PDL BIOPHARMA, INC. (2)
Phio Pharmaceuticals Corp. (1)
PIERIS PHARMACEUTICALS, INC. (3)
PLURISTEM THERAPEUTICS INC (1)
PMV Pharmaceuticals, Inc. (2)
POLARITYTE, INC. (4)
PORTOLA PHARMACEUTICALS INC (1)
Poseida Therapeutics, Inc. (4)
Praxis Precision Medicines, Inc. (3)
PRECISION BIOSCIENCES INC (9)
Prelude Therapeutics Inc (3)
Prevail Therapeutics Inc. (1)
Prometheus Biosciences, Inc. (2)
Protagonist Therapeutics, Inc (2)
PROTEON THERAPEUTICS INC (1)
PROTEOSTASIS THERAPEUTICS, INC. (7)
Prothena Corp plc (2)
PTC THERAPEUTICS, INC. (4)
Pyxis Oncology, Inc. (1)
Radius Health, Inc. (1)
RAPT Therapeutics, Inc. (4)
RECURSION PHARMACEUTICALS, INC. (10)
Regeneron Pharmaceuticals (2)
REGENXBIO Inc. (7)
Regulus Therapeutics Inc. (6)
Relay Therapeutics, Inc. (1)
Repare Therapeutics Inc. (11)
Replimune Group, Inc. (2)
Retrophin, Inc. (1)
Revolution Medicines, Inc. (9)
REXAHN PHARMACEUTICALS, INC. (6)
RHYTHM PHARMACEUTICALS, INC. (1)
RIGEL PHARMACEUTICALS INC (2)
RITTER PHARMACEUTICALS INC (1)
ROCKET PHARMACEUTICALS, INC. (1)
Rubius Therapeutics, Inc. (2)
Sage Therapeutics, Inc. (1)
Sana Biotechnology, Inc. (2)
SANGAMO THERAPEUTICS, INC (7)
Savara Inc (1)
Scholar Rock Holding Corp (1)
SEATTLE GENETICS INC (3)
SELECTA BIOSCIENCES INC (2)
SELLAS Life Sciences Group, Inc. (2)
Sensei Biotherapeutics, Inc. (1)
SERA PROGNOSTICS, INC. (3)
Seres Therapeutics, Inc. (2)
Shattuck Labs, Inc. (2)
Sierra Oncology, Inc. (2)
Sigilon Therapeutics, Inc. (5)
Silverback Therapeutics, Inc. (4)
SOLENO THERAPEUTICS INC (1)
Solid Biosciences Inc. (2)
Sorrento Therapeutics, Inc. (2)
Spectrum Pharmaceuticals, Inc. (2)
Spero Therapeutics, Inc. (1)
Spinning Eagle Acquisition Corp. (3)
Spring Bank Pharmaceuticals, Inc. (1)
SpringWorks Therapeutics, Inc. (1)
SPRUCE BIOSCIENCES, INC. (2)
SQZ Biotechnologies Co (1)
Stellar Biotechnologies, Inc. (2)
Stoke Therapeutics, Inc. (4)
Summit Therapeutics Inc. (1)
Surface Oncology, Inc. (1)
SUTRO BIOPHARMA, INC. (1)
Syros Pharmaceuticals, Inc. (2)
T2 Biosystems, Inc. (4)
Talaris Therapeutics, Inc. (1)
Taysha Gene Therapies, Inc. (2)
TCR2 THERAPEUTICS INC. (1)
TENAX THERAPEUTICS, INC. (1)
Tenaya Therapeutics, Inc. (2)
Tocagen Inc (2)
Tonix Pharmaceuticals Holding Corp. (1)
TScan Therapeutics, Inc. (2)
Turning Point Therapeutics, Inc. (7)
Twist Bioscience Corp (4)
Tyra Biosciences, Inc. (3)
U.S. Stem Cell, Inc. (2)
Ultragenyx Pharmaceutical Inc. (10)
uniQure N.V. (3)
Unum Therapeutics Inc. (3)
UroGen Pharma Ltd. (2)
Vaccitech plc (1)
Vanda Pharmaceuticals Inc. (2)
Vaxart, Inc. (4)
Vaxcyte, Inc. (4)
VBI Vaccines Inc (14)
Vericel Corp (2)
Vertex Pharmaceuticals Inc (2)
Verve Therapeutics, Inc. (4)
VICAL INC (2)
Viela Bio, Inc. (1)
Vigil Neuroscience, Inc. (1)
Vir Biotechnology, Inc. (2)
VistaGen Therapeutics, Inc. (1)
VITAL THERAPIES INC (1)
VITRO DIAGNOSTICS INC (1)
Vor Biopharma Inc. (3)
Voyager Therapeutics, Inc. (4)
Werewolf Therapeutics, Inc. (3)
Xencor Inc (8)
Xenon Pharmaceuticals Inc. (3)
Xilio Therapeutics, Inc. (1)
XOMA Corp (2)
ZAFGEN, INC. (2)
Zai Lab Ltd (1)
Zentalis Pharmaceuticals, LLC (9)
ZIOPHARM ONCOLOGY INC (5)
Zymeworks Inc. (2)

Recent Contracts

Amendment to Office Lease Agreement between UCB, Inc. and GeoVax, Inc (GeoVax Labs, Inc., Filed With SEC on March 23, 2023)
First Amendment to Lease Termination Agreement, dated December 29, 2022, by and between Torrey Pines Science Center Limited Partnership and Eterna Therapeutics Inc (NTN BUZZTIME INC, Filed With SEC on March 20, 2023)
Lease Termination Agreement, dated November 30, 2022, by and between Torrey Pines Science Center Limited Partnership and Eterna Therapeutics Inc (NTN BUZZTIME INC, Filed With SEC on March 20, 2023)
Sublease Agreement, dated October 18, 2022, by and between E.R. Squibb & Sons, LLC and Eterna Therapeutics Inc (NTN BUZZTIME INC, Filed With SEC on March 20, 2023)
Second Amendment to Lease, dated February 16, 2023, by and between Eiger BioPharmaceuticals, Inc. and the McDonald Family Co. LLC (Eiger BioPharmaceuticals, Inc., Filed With SEC on March 17, 2023)
Amendment to Office Lease, dated December 16, 2022, by and between 0846869 B.C. Ltd. and Achieve Life Sciences Technologies Inc (ACHIEVE LIFE SCIENCES, INC., Filed With SEC on March 16, 2023)
Amendment to Deed of Lease, dated as of November 16, 2021, between Key West MD Owner LLC and Registrant (MAXCYTE, INC., Filed With SEC on March 15, 2023)
Deed of Lease, dated as of May 27, 2021, between Key West MD Owner LLC and Registrant (MAXCYTE, INC., Filed With SEC on March 15, 2023)
Fourth Amendment to Lease, dated March 13, 2023, by and between Celcuity Inc. and West Glen Development I, LLC (Celcuity Inc., Filed With SEC on March 15, 2023)
First Amendment to Lease Agreement by and between ARE-770/784/790 Memorial Drive, LLC and the Registrant, dated March 21, 2017 (Jounce Therapeutics, Inc., Filed With SEC on March 10, 2023)
Form of First Amendment of Lease, dated December 30, 2022 (Cellectar Biosciences, Inc., Filed With SEC on March 9, 2023)
Sublease Agreement with Atara Biotherapheutics, Inc., dated October 28, 2022 (RIGEL PHARMACEUTICALS INC, Filed With SEC on March 7, 2023)
Fourth Amendment to Lease, dated May 25, 2021, by and between Ardelyx, Inc. and 34175 Ardenwood Venture, LLC (ARDELYX, INC., Filed With SEC on March 2, 2023)
Consent to Sublease Agreement, dated as of October 28, 2022, by and among HCP LS Brisbane, LLC, Arcus Biosciences, Inc., and Prothena Biosciences Inc (Prothena Corp plc, Filed With SEC on February 28, 2023)
Sublease, dated as of October 28, 2022, by and between Arcus Biosciences, Inc. and Prothena Biosciences Inc (Prothena Corp plc, Filed With SEC on February 28, 2023)
Second Amendment to Commercial Lease, executed December 15, 2022, by and between the Registrant and Tannos Land Holdings III, LLC (CASTLE BIOSCIENCES INC, Filed With SEC on February 28, 2023)
Third Amendment to Standard Office Lease, dated February 9, 2023, by and between the Registrant and Alturas Siete, II, LLC (CASTLE BIOSCIENCES INC, Filed With SEC on February 28, 2023)
Fifth Amendment to Standard Office Lease, dated October 24, 2022, by and between the Registrant and Alturas Siete I, LLC (CASTLE BIOSCIENCES INC, Filed With SEC on February 28, 2023)
Sixth Amendment to Lease, dated November 14, 2022, by and between the Company and 111 Lemon Investors LLC (Xencor Inc, Filed With SEC on February 27, 2023)
First Amendment to Office Lease, date February 11, 2019, by and between Valeritas, Inc. and BRP 293 Equity Partners, LLC (MANNKIND CORP, Filed With SEC on February 23, 2023)
Office Lease, dated May 10, 2017, by and between Valeritas, Inc. and RFP Lincoln 293 LLC (MANNKIND CORP, Filed With SEC on February 23, 2023)
Fifth Amendment to the Lease Agreement between the registrant and 28159 Avenue Stanford Properties, LLC, (formerly RIF III-Avenue Stanford LLC), dated January 26, 2023, as amended) (Avita Therapeutics, Inc., Filed With SEC on February 23, 2023)
First Amendment to Lease Agreement, dated November 15, 2022 between Registrant and ARE-MA Region No. 55, LLC (Editas Medicine, Inc., Filed With SEC on February 22, 2023)
Lease Termination Agreement, dated as of February 7, 2023 (TENAX THERAPEUTICS, INC., Filed With SEC on February 10, 2023)
Lease Extending and Amending Agreement dated as of December 31, 2022 by and between Edesa Biotech Research, Inc. and 1968160 Ontario, Inc (Stellar Biotechnologies, Inc., Filed With SEC on February 10, 2023)
Lease Agreement, dated September 6, 2022, between OncoSec Medical Incorporated and Mountain View Office Park, L.L.C (ONCOSEC MEDICAL Inc, Filed With SEC on February 1, 2023)
First Amendment to Lease, dated December 9, 2022, by and between Seres Therapeutics, Inc. and BMR-Sidney Research Campus, LLC (f/k/a BMR 200-Sidney Street LLC) (Seres Therapeutics, Inc., Filed With SEC on December 14, 2022)
Agreement for Termination of Lease, dated December 12, 2022, by and between Rubius Therapeutics, Inc. and ARE-MA Region No. 58, LLC (Rubius Therapeutics, Inc., Filed With SEC on December 14, 2022)
Lease Agreement, by and between the Company and 611 Gateway Center LP, dated December 1, 2022 (SPRUCE BIOSCIENCES, INC., Filed With SEC on December 2, 2022)
Lease Agreement between 1960 South 4250 West LLC and PolarityTE MD, Inc., dated December 1, 2022 (POLARITYTE, INC., Filed With SEC on December 1, 2022)
October 5, 2022 Lease extension for Riverton office (HEMISPHERX BIOPHARMA INC, Filed With SEC on November 14, 2022)
Second Amendment to Single-Tenant Triple Net Lease, dated August 8, 2022, by and between Prelude Therapeutics Incorporated and CRISP Partners LLC (Prelude Therapeutics Inc, Filed With SEC on November 14, 2022)
Third Amendment to Office Lease, dated effective October 7, 2022, by and between the Company and Kilroy Realty, L.P (Constellation Alpha Capital Corp., Filed With SEC on November 14, 2022)
Third Amendment to Lease by and between R (MIRAGEN THERAPEUTICS, INC., Filed With SEC on November 14, 2022)
Lease dated September 10, 2021 by and between iBio, Inc., and San Diego Inspire 4, LLC (iBio, Inc., Filed With SEC on November 14, 2022)
Fourth Amendment to the Lease Agreement, dated October 18, 2022, by and between NW Austin Officer Partners LLC and Molecular Templates, Inc (Molecular Templates, Inc., Filed With SEC on November 10, 2022)
Amendment to Office Lease, by and between 89bio, Inc. and King Family Irrevocable Trust, dated as of August 31, 2022 (89bio, Inc., Filed With SEC on November 10, 2022)
Lease Agreement dated September 24, 2015, by and between NSTX, Inc. and Karlin McCallen Pass, LLC (Natera, Inc., Filed With SEC on November 9, 2022)
First Amendment to Lease Agreement dated January 26, 2016, by and between NSTX, Inc. and Karlin McCallen Pass, LLC (Natera, Inc., Filed With SEC on November 9, 2022)
Second Amendment to Lease, effective October 10, 2022, by and between Eastland Regency, L.C. and the Registrant (SERA PROGNOSTICS, INC., Filed With SEC on November 9, 2022)